Jamie Evans

Jamie Evans is a Senior Process Engineer in Utilities at Grifols, with a tenure beginning in October 2020, following the acquisition of a $300 million+ blood plasma fractionation plant formerly owned by GC Biotherapeutics. Prior experience includes a role as a Quality Engineering Specialist at GC Biotherapeutics Inc. from July 2019 to October 2020, and as a Critical Utility Specialist at PnuVax SL Biopharmaceuticals from March 2012 to July 2019. Jamie Evans possesses extensive expertise in managing clean and dirty utilities, as well as validating large-scale Purified Water and WFI Systems. Jamie Evans holds a Bachelor of Science in Engineering Chemistry from Queen's University, earned between 2007 and 2011.